References
- Khachaturian, Z. S. : Diagnosis of Alzhemier's disease. Arch. Neurol. 42, 1097 (1985) https://doi.org/10.1001/archneur.1985.04060100083029
- Selkoe, D. J. : Translating cell biology into therapeutic advances in Alzhemier's disease. Nature 399, A23 (1999) https://doi.org/10.1038/19866
- Hollander, E., Mohs, R. C. and Davis, K. L. : Cholinergic approaches to the treatment of Alzheimer's disease. Br. Med. Bull. 142, 97 (1986)
- Pietrzik, C. and Behl, C. : Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application. Int. J. Exp. Pathol. 86, 173 (2005) https://doi.org/10.1111/j.0959-9673.2005.00435.x
- Silverberg, G. D., Mayo, M., Saul, T., Carvalho, J. and McGuire, D. : Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers. Expert. Rev. Neurother. 4, 97 (2004) https://doi.org/10.1586/14737175.4.1.97
- Cottingham, M. G., Voskuil, J. L. and Vaux, D. J. : The intact human acetylcholinesterase C-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers. Biochemistry 42, 10863 (2003) https://doi.org/10.1021/bi034768i
- Prous, J., Rabasseda, X. and Castaner, J. : SDZ-ENA-713 cognition enhancer acetylcholinesterase inhibitor. Drugs Future 19, 656 (1996)
- Lilienfeld, S. : Galantamine - a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. CNS Drug Rev. 8, 159 (2002) https://doi.org/10.1111/j.1527-3458.2002.tb00221.x
- Cottingham, M. G., Hollinshead, M. S. and Vaux, D. J. : Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide. Biochemistry 41, 13539 (2002) https://doi.org/10.1021/bi0260334
- De Ferrari, G. V., Canales, M. A., Shin, I., Weiner, L. M., Silman, I. and Inestrosa, N. C. : A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation. Biochemistry 40, 10447 (2001) https://doi.org/10.1021/bi0101392
- Kurz, A. : The therapeutic potential of tacrine. J. Neural Transm. Suppl. 54, 295 (1998)
- Sugimoto, H. : Donepezil hydrochloride: a treatment drug for Alzheimer's disease. Chem. Rec. 1, 63 (2001) https://doi.org/10.1002/1528-0691(2001)1:1<63::AID-TCR9>3.0.CO;2-J
- Jann, M. W. : Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy 20, 1 (2000) https://doi.org/10.1592/phco.20.1.1.34664
- Zarotsky, V., Sramek, J. J. and Cutler, N. R. : Galantamine hydrobromide: an agent for Alzheimer's disease. Am. J. Health Syst. Pharm. 60, 446 (2003)
- Barril, X., Orozco, M. and Luque, F. J. : Towards improved acetylcholinesterase inhibitors: a structural and computational approach. Mini. Rev. Med. Chem. 1, 255 (2001) https://doi.org/10.2174/1389557013406828
- Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A. and Klein, W. L. : Alzheimer's disease-affected brain: presence of oligomeric A-beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. USA 100, 10417 (2003)
- Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F. and Tycko, R. : A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints fromsolid state NMR. Proc. Natl. Acad. Sci. USA 99, 16742 (2002)
- Luhrs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Dobeli, H., Schubert, D. and Riek, R. : 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. USA 102, 17342 (2005)
- Massi, F. and Straub, J. E. : Structural and dynamical analysis of the hydration of the Alzheimer's beta-amyloid peptide. J. Comput. Chem. 24, 143 (2003) https://doi.org/10.1002/jcc.10101
- Santini, S., Mousseau, N. and Derreumaux, P. : In silico assembly of Alzheimer's Abeta16-22 peptide into beta-sheets. J. Am. Chem. Soc. 126, 11509 (2004) https://doi.org/10.1021/ja047286i
- Greig, N. H., Sambamurti, K., Yu, Q. S., Brossi, A., Bruinsma, G. B. and Lahiri, D. K. : An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Curr. Alzheimer Res. 2, 281 (2005) https://doi.org/10.2174/1567205054367829
- Clarimon, J., Bertranpetit, J., Calafell, F., Boada, M., Tarraga, L. and Comas, D. : Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1. J. Neurol. 250, 956 (2003) https://doi.org/10.1007/s00415-003-1127-8
-
Patrice, T. :
$\beta$ -Amyloid aggregation inhibitors for Treatment of Alzheimer's disease: Dream or Reality- Mini Reviews in Medicinal Chemistry 1, 175 (2001) https://doi.org/10.2174/1389557013407098